gataparsen development code antisense oligonucleotide complementarily binds survivin mrna inhibits expression tumor investigated number different targeted survivin prevents cells completed phase ii trial acute myeloid phase ii trial nonsmall cell lung cancer phase ii trial hormonerefractory prostate cancer run early antineoplastic immunomodulatory drug article stub help wikipedia expanding httpsenwikipediaorgwikigataparsen